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Abstract: MicroRNAs (miRNAs) have been recently described as small noncoding RNAs that are involved in numerous crucial
physiological processes, such as cell cycles, differentiation, development, and metabolism. Thus, dysregulation of these molecules
could lead to several severe disorders, including breast cancer (BC). Ongoing investigations in malignant growth diagnostics have
distinguished miRNAs as promising disease biomarkers. As with any other mRNAs, single nucleotide polymorphisms (SNPs) in DNA
sequence encoding for miRNA (miR-SNPs) indeed lead to potential changes in the function of miRNA. In this study, miR-SNPs located
in different miRNA sequence regions, which have been associated with BC in different ways, and the potential mechanisms of how these
miR-SNPs develop the risk of the disease were discussed.
Key words: Breast cancer, microRNA, miRNA, single nucleotide polymorphism, SNP

1. Introduction
Breast cancer (BC) is the most widely recognized
disease among women worldwide. Together with
several identified penetrance BC predisposition genes,
microRNAs (miRNAs) have gained more attention due to
their relationship with BC development (Wightman et al.,
1993). MiRNAs are negative regulators of gene expression
acting on mRNA (Catalanotto et al., 2016). They have
been implicated in various physiological processes, such
as development, metabolism, differentiation, proliferation,
and responses to stress (Hu and Coller, 2012; Iwakawa and
Tomari, 2015). The bioinformatics data system of about
2500 known mature miRNAs in human was published,
with an estimation of more than 60% mRNAs in the
mammalian genome being regulated by miRNAs (Stoicea
et al., 2016).
MiRNAs are single-stranded noncoding RNA
molecules of approximately 22–24 nucleotides in length
that regulate posttranscriptional gene expression (StaregaRoslan et al., 2011). The biogenesis of miRNAs (O’Brien et
al., 2018) starts in the nucleus, where primary miRNA (primiRNA) is first transcribed from its gene (miRNA gene),
is cleaved, and then modified to form precursor miRNA
(pre-miRNA). This precursor is then transported to the
cytoplasm to join in another process that generatesan

imperfect miRNA duplex that contains the mature miRNA
strand andits complementary strand, miRNA*. Through a
separation process, the miRNA* strand is degraded and
only a mature miRNA strand remains. Finally, the mature
miRNA comes into contact with the argonaute protein
of the RNA-induced silencing complex (RISC) to form a
stable active miRNA-RISC complex that can specifically
bind to target mRNA and promote the translational
inhibition or degradation of this mRNA.
Single nucleotide polymorphisms (SNPs) occur as
frequently as 1 per 1 kbp in the genome (Shastry, 2009).
Among these SNPs, those that lie within miRNA genes
(miR-SNPs) have been found to be involved in the interpretation of the essential transcript, the processing of
pri-miRNA and pre-miRNA and the interactions between
miRNA and mRNA. MiR-SNPs in seed regions of miRNAs,
which are regions liable for the binding between miRNA
and mRNA, can interrupt miRNA binding or be destructive. Moreover, SNPs can make new connections between
miRNA seed regions and target mRNA by changing the
sequence homology (Chen et al., 2008). Polyadenylation,
protein-mRNA connections, and miRNA-mRNA interactions can be modified by miR-SNPs in the untranslated
regions (3′UTRs) of mRNA. These alterations can effectively affect mRNA stability and translation efficiency

* Correspondence: nthue@hcmus.edu.vn

284

This work is licensed under a Creative Commons Attribution 4.0 International License.

NGUYEN et al. / Turk J Biol
(Nicoloso et al., 2010). Correspondingly, SNPs in primary
and precursfor miRNA sequences can influence miRNA
production and stability, as well as miRNA-mRNA interactions, prompting changes in the expression of miRNA
target genes (Ryan et al., 2010). Despite missing biological validation, case-control studies have provided proof of
the relationship of miR-SNPs and the risk of cancer. These
investigations have contrasted at the level of practical support regarding the expected interaction, mechanical understanding, and validation status.
Such miR-SNPs can cause an increased risk of several
cancers, including BC (Zheng et al., 2011). All sorts of
miR-SNP can be potentially novel biomarker candidates
for disease susceptibility testing, personalized prognosis,
and the clinical treatment of BC patients (Hoffman et
al., 2009; Sung et al., 2012; Ryan, 2017). In this study, the
critical role of miR-SNPs and their potential mechanisms
in BC will be discussed.
2. SNPs in pri-miRNA sequence and BC
The hairpin double-stranded stem structure, along with a
terminal loop and the 2 single-stranded flanking regions of
pre-miRNAs play a crucial role in the processing executed
by the Drosha-DCGR8 complex (Wahid et al., 2010).
Therefore, SNPs that are located within these regions of the
miRNA genes may alter molecular processing and affect
miRNA maturation (Han et al., 2004; Zeng and Cullen,
2005; Sun et al., 2009; Auyeung et al., 2013; Cammaerts
et al., 2015). In addition, transcriptional elements like
the promoter regions have been reported to be present in
pri-miRNA sequences (Song Gao et al., 2010). Hence, the
presence of any variant within the long flanking sequence
of pri-miRNA suggests an alteration in the recruitment
of necessary factors required for miRNA transcription.
Thus far, it has been suggested that functional SNPs in
pri-miRNA sequences (pri-miR-SNPs) are related to the
processing of mature miRNA and risk of cancer. In a study
of SNPs in primary transcripts of miRNAs, 4 SNPs in primiR-3065 showed the possibility of being associated with
BC. Particularly, the impairedmiR-3065 processing caused
by these 4 SNPs lead to the downregulation of mature miR3065 and reduced the inhibition of its target oncogenes
(Bensen et al., 2018).
In this study, 4 other SNPs, rs353291, rs1053872,
rs4284505, and rs12976445, in the primary transcripts of 4
different miRNAs were discussed in terms of their effects
on mature miRNA levels, the expression of their target
genes, and their relationship with the risk of BC (Table).
2.1. Effect of rs353291 (A/G) on pri-miR-145 in breast
tumorigenesis
SNP rs353291 is located in pri-miR-145, 450 bp upstream
of the miR-145 gene. One of thesemiR-145 targets is
epidermal growth factor receptors (EGFRs) (Cho et al.,

2011), which are involved in cell proliferation and have
been well-proven to be related to BC (Yan et al., 2014).
There have been 2 possible mechanisms found through
which rs353291 can be involved in BC. First, the SNP
lies within the binding site of transcriptional factors.
Thus, the variation of rs353291 may decrease miR-145
expression, leading to an increase in the expression
level of its oncogenic target gene, and finally resulting in
tumorigenesis. In fact, a study found that the expression
level of miR-145 was significantly downregulated in a
variety of tumors (Cho et al., 2011). Moreover, the presence
of the G allele at rs353291 was shown to increase the risk of
developing BC in 2 independent case-control Australian
Caucasian populations [G vs. A: odd ratio (OR) = 1.37,
95% confidence interval (95% CI) = 1.01–1.84, P = 0.041
and OR = 1.31, 95% CI = 1.04–1.70, P = 0.023] (ChaconCortes et al., 2015a). Hence, the G variant of rs353291
might have a role in decreasing miR-145 expression. In
the second mechanism, rs353291 might indirectly cause
abnormalities in the length of telomeres. GG-genotype
individuals were found to have longer telomere when
compared with those who had AA or AG genotypes (P
= 0.005) (Duan et al., 2020). Both shorter and longer
telomere can lead to cancers (Aviv et al., 2017; McNally
et al., 2019). Therefore, it is possible that the G variation
of rs353291 may first decrease miR-145 expression which,
in turn, increases the expression level of longer-telomere
association gene, resulting in the increased risk of BC.
2.2. Effect of rs1053872 (C/G) on pri-miR-101 in breast
tumorigenesis
SNP rs1053872 is located in pri-miR-101-2, 10 kb
downstream from the miR-101-2 gene. This SNP has
been predicted to be in the extended sequence flanking
3′ side of the pre-miR-101, which may affect the cleavage
of Drosha and correspondingly, the processing of mature
miR-101-3p. In fact, the G allele carriers were shown to
be significantly associated with the increased risk of BC
[(CG + GG vs. CC: OR = 1.179, 95% CI = 1.040–1.337,
P = 0.010) (Chen et al., 2014a)] and miR-101-3p have
been revealed to be downregulated in BC (Wang et al.,
2012; 2014). Therefore, the G allele of rs1053872 might
be related to the inhibition of miR-101-3p maturation
in BC. Although the precise mechanism of miR-101-3p
in BC regulation is not entirely clear, miR-101-3p was
observed to inhibit proliferation, invasion, and metastasis
via targeting Stathmin1 (STMN1) and C-X-C chemokine
receptor type 7 (CXCR7)(Wang et al., 2012; Li et al., 2015)
and promote apoptosis by targeting Janus kinase 2 (JAK2)
in BC cells (Wang et al., 2014).
2.3. Effect of rs4284505 (A/G) on pri-miR-17HG in
breast tumorigenesis
SNP rs4284505 is located in the intron of the miR-17 host
gene (miR-17HG), 2kb upstream of miR-17 and miR-
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Table. Effect of the risk allele of miR-SNP on the BC risk via regulation of the expression of miRNA and related genes.
SNP-risk allele SNP position

Affected miRNA
expression

Related gene
expression

rs353291-G

↓ miR-145

↑ EGFR

rs1053872-G

↓ miR-101

↑ STMN1, ↑ CXCR,
Increased risk
↑ JACK2

Wang et al. (2012), Chen et al.
(2014a), Wang et al. (2014)

↓ miR-17HG

↑ CCDN1

Increased risk

Yu et al. (2008), Chacon-Cortes et
al.(2015b)

Increased risk

Schulman et al. (2005), Wu and
Belasco (2005), Scott et al. (2007),
Lehmann et al. (2013), Jiao et al.
(2014), Yamagata et al. (2014)

rs4284505-G

Pri-miRNA
sequence

rs12976445-C

↓ miR-125a

↑ ERBB2

BC risk association
Reference
study
Cho et al. (2011), Yan et al. (2014),
Increased risk
Chacon-Cortes et al.(2015a),
Duan et al. (2020)

rs895819-C

↓ miR-27a

↑ FBW7

Decreased risk

Zeng et al. (2005), Yang et al.
(2010), Lerner et al. (2011), Xiong
et al. (2013), Zhang et al. (2013),
Dai et al. (2015), Zhang et al.
(2017b)

rs2682818-A

↓ miR-618

↓ PTEN

Increased risk

Fu et al. (2014), Morales et al.
(2016), Feng et al. (2019)

↓ miR-423

↑ CDKN1A

Increased risk

Lin et al. (2011), Smith et al.
(2012), Zhao et al. (2015), Morales
et al. (2016), Wazir et al. (2019)

rs6505162-C

Pre-miRNA
sequence

rs2043556-G

↓ miR-605

↑ MDM2

Increased risk

Xiao et al. (2011), Chen et al.
(2014b), Zhou et al. (2014), Said
and Malkin (2015), Morales et al.
(2018), Kazemi and Vallian (2020)

rs4919510-G

↓ miR-608

↑ HSF1

Increased risk

Cheng et al. (2012), Huang et al.
(2012), Hashemi et al. (2016)

↑ miR-196a2

↓ HOXD10, ↑ TOX3 Increased risk

Easton et al. (2007), Ma et al.
(2007), Stacey et al. (2007),
Hoffman et al. (2009), Hu et al.
(2009), Qiu et al. (2011), Minh et
al. (2018)

rs3746444-G

↓ miR-499a

↑ SOX

Increased risk

Alshatwi et al. (2012), Li et al.
(2013), Yan et al. (2017), Zhang et
al. (2017a)

rs2910164-C

↑ miR-146a

↑ TRAF6

Increased risk

Deng (2006), Shen et al. (2008),
Lian et al. (2012), Dai et al. (2015),
Minh et al. (2018)

rs11614913-C
Mature miRNA
sequence

↑ upregulation; ↓ downregulation

18a genes. Intronic variants have been demonstrated to
affect the transcription, the splicing proficiency of their
host genes, and the expression of different transcripts.
Additionally, some variants may influence the expression
of distant genes. Therefore, rs4284505 might affect the
processing of miR-17HG, which has been known as an
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essential regulator of genes involved in BC pathways, such
as upregulating (Cyclin D1) CCND1 (Yu et al., 2008). A
study from Chacon-Cortes et al. revealed that a rs4284505
variant of miR-17HG was closely related to the risk of BC
in 2 Australian case-control populations (P = 0.01 and P
= 0.03), and the presence of the A allele appeared to have
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a protective effect on susceptibility to BC (Chacon-Cortes
et al., 2015b). Therefore, the A allele of rs4284505 might
increase the miR-17HG expression.
2.4. Effect of rs12976445 (C/T) on pri-miR-125a in breast
tumorigenesis
SNP rs12976445, which was found to be significantly
associated with worse survival in BC (P = 0.04) (Jiao et
al., 2014), is located in pri-miR-125a, 54bp upstream of
the miR-125a gene. How rs12976445 variants affect the
processing of pre-miR-125a remains to be elucidated. One
hypothesis was that rs12976445 may interfere with the
interaction between Drosha and pri-miRNA, subsequently
reducing miR-125a maturation or affecting miR-125a level
(Yamagata et al., 2014). Studies have shown that the SNP
was linked to a decline in miR-125a levels. For instance,
Lehmann et al. found that the samples that had allele C
of SNP rs12976445 (either heterozygous or homozygous)
exhibited a decrease of 85% (P = 0.024) in the miR-125a
level when compared with those that contained TT
variant (Lehmann et al., 2013). Another study conducted
by Scott et al. revealed that miR-125a was significantly
downregulated in Erb-B2 receptor tyrosine kinase 2
(ERBB2)-amplified BCs (Scott et al., 2007). Notably,
tumor samples with the CC or CT genotype of rs12976445
seemed to have had higher ERBB2 mRNA level than those
with the TT genotype, with an increase of 2.4-fold (P =
0.044) (Lehmann et al., 2013). Because ERBB2 is one of the
target genes of miR-125a (Schulman et al., 2005; Wu and
Belasco, 2005; Scott et al., 2007), it might be possible that
the CC or CT genotype of rs12976445 can increase the risk
of BC via the downregulation of miR-125a,followed by the
upregulation of ERBB2.
3. SNPs in pre-miRNA sequence and BC
In the pre-miRNA structure, the sequence at 2-nucleotide
overhanging the unpaired flanking arms and within
the hairpin are essential for the accurate binding of
Exportin-5/Ran-GTP complex and Dicer (Yi et al., 2003;
Kim, 2004; Zhang et al., 2004; Tsutsumi et al., 2011; Gu et
al., 2012; Tian et al., 2014). Therefore, SNPs located within
pre-miRNA sequences (pre-miR-SNPs) could lead to a
shift in the processing sites during the miRNA/miRNA*
duplex biogenesis, resulting in the alteration of mature
miRNAs and subsequently, target mRNAs.
In BC, 44 pre-miR-SNPs (rs2682818, rs6505162,
rs2043556, and rs895819) were found to have an effect on
the level of their mature miRNAs. The alterations of miRNA
expression consequently upregulated the expression of
oncogenic target genes or downregulated the expression
of tumor suppressor genes, resulting in as increased risk of
BC. The potential mechanisms of pre-miR-SNPs associated
with the risk of BC affecting the mature miRNAs and target
gene expressions are summarized in the Table.

3.1. Effect of rs895819 (A/C) on pre-miR-27a in breast
tumorigenesis
SNP rs895819 (A/C) is in pre-miR27a and is located in the
terminal loop (Figure 1). Hence, this SNP can change the
size of the terminal loop and affect the binding of some
components of the Drosha or Dicer complexes, such as
KSRP, thus interfering with this miRNA maturation (Zeng
et al., 2005; Yang et al., 2010). In fact, studies by Zeng et
al. and Xiong et al. showed that the C allele of rs895819
caused a decrease in pre-miR-27a products, as well as
mature miR-27a expression (Zeng et al., 2005; Xiong et
al., 2013), leading to an upregulation of the F-box/WD
repeat-containing protein 7 (FBW7) (Lerner et al., 2011;
Xiong et al., 2013), which in turn downregulated multiple
oncoproteins and reduced the chance of tumorigenesis
(Lerner et al., 2011).
The protective impact of the C allele on BC development
has been confirmed in several case-control studies,
including in a Chinese population [C vs. A: OR = 0.628,
95% CI = 0.410–0.961, (Zhang et al., 2013); C vs. A: OR =
0.93, 95% CI = 0.87–0.99 (Zhang et al., 2017b)], German
population [C vs. A: OR = 0.88, 95% CI = 0.78–0.99, P =
0.0287 (Yang et al., 2010)], and in all of the populations
in a meta-analysis [C vs. A: OR = 0.91, 95% CI = 0.85–
0.98, P = 0.02 (Dai et al., 2015)]. SNP rs895819 was also
associated with the risk of BC in BRCA2 mutation carriers
(Kontorovich et al., 2010), which indicated that this SNP
may be involved in familial BC development.
3.2. Effect of rs2682818 (A/C) on pre-miR-618 in breast
tumorigenesis
SNP rs2682818 (A/C) is located in pre-miR-618. The A
allele has been predicted to change the first internal stemloop of miR-618 and its structure contains a small internal
loop at the Drosha processing site (Figure 1). This SNP
position may affect Dicer and Drosha processing, which
may alter the production of pre-miR-618 and mature
miR-618. Indeed, Fu et al. (2014) reported that the Aallele
was associated with the decreased level of mature miR618. The decrease in mature miR-618 levels may initiate
BC tumorigenesis by deregulating miR-618-dependent
pathways. Phosphatase and tensin homolog (PTEN), a
BC-associated protein, was one of the predicted targets of
miR-618. The A allele reduced the binding affinity of miR618 to the 3′UTRs of PTEN and thus, might deactivate
the tumorigenesis. The enhanced risk of BC of miR-618
rs2682818 variant was revealed. The A allele carriers were
observed to be associated with increased risk of BC [A vs.
C: OR = 1.3, 95% CI = 1.0−1.8, P = 0.03; CA + AA vs. CC:
OR = 1.4, 95% CI = 1.0−2.0, P = 0.02 (Morales et al., 2016)]
in a South American population. In a meta-analysis, an
increased risk of BC caused by rs2682818 was discovered
in heterozygote genetic model (AC vs. CC: OR = 1.291,
95% CI = 1.012–1.648, P = 0.040) and dominant contrast
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Figure 1. Predicted secondary structure of pre-miRNA with 2 alleles of pre-miR-SNP. Sites of the SNPs are indicated with arrows. This
figure was predicted using the webserver at https://rna.urmc.rochester.edu/RNAstructureWeb/.

model (AA + AC vs. CC: OR = 1.280, 95% CI = 1.009–
1.623, P = 0.042) (Feng et al., 2019).
3.3. Effect of rs6505162 (A/C) on pre-miR-423 in breast
tumorigenesis
SNP rs6505162 (A/C) resides within the single-stranded
flanking segments of pre-miR-423, 12 bp from the cleavage
site of DGCR8 and approximately 11 bp from the stemssRNA junction (Han et al., 2006). Although the A and the
C alleles of rs6505162 have been predicted to have the same
structure (Figure 1), the SNP was hypothesized to alter the
maturation of miR-423 due to its proximate location from
the DGCR8 cleavage site. In fact, the C allele of rs6505162
was found to be involved in a process that prevents primiR-423 from being normally processed into 2 mature
miRNAs (Zhao et al., 2015). In addition, the mature miR423 was reported to downregulate cyclin-dependent kinase
inhibitor 1A (CDKN1A) (p21Cip1/Waf1) expression
by directly targeting the 3′UTR of CDKN1A (Lin et al.,
2011), which functions as a key inhibitor of S-phase
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DNA synthesis and cell cycle progression. A significantly
direct correlation was found in cancerous tissue between
telomerase reverse transcriptase and CDKN1Ain the
context of human BC (Wazir et al., 2019). Therefore,
rs6505162 might be related to the development of BC via
miR-423 and CDKN1A.
Indeed, the CC genotype of rs6505162was observed to
reduce the risk of BC development (CC vs. AA: OR = 0.50,
95% CI = 0.27–0.92, P = 0.03) in Caucasian Australian
women (Smith et al., 2012). Furthermore, the AC genotype
of rs6505162 was shown to be related to increased risk of
BC in BRCA2 carriers (Kontorovich et al., 2010), which
indicated that this SNP may have a role in familial BC. A
study of South American women also found that the A
allele and AA genotype of rs6505162 were significantly
associated with increased risk of familial BC in people
with a strong family history of BC (A vs. C: OR =1.3, 95%
CI = 1.0–1.7, P = 0.04; AA vs. CC: OR = 1.7, 95% CI = 1.0–
2.0, P = 0.05) (Morales et al., 2016). Interestingly, a study
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in Saudi Arabia found that the third allele of this SNP
(allele T) was associated with increased BC susceptibility
(T vs. C: OR = 2.63, 95% CI = 1.77–3.91, P = 0.001) (Mir
et al., 2018). These findings suggested that the non-C
allele of rs6505162 may increase the level of mature miR423, thereby inhibiting the expression of CDKN1A and
inducing breast tumorigenesis.
3.4. Effect of rs2043556 (A/G) on pre-miR-605 in breast
tumorigenesis
SNP rs2043556 (A/G) is located in the precursor region
of the miR-605 gene and influences the processing of the
miRNA. The G allele of rs2043556 has been predicted to
create an additional internal loop around the cleavage
site of Dicer, while the A allele created a complementary
loop (Figure 1). The structural change caused by the G
allele implies a possible role of it in decreasing mature
miR-605 levels (Said and Malkin, 2015). Furthermore,
miR-605 has been predicted to inhibit major oncogene
expression (Kazemi and Vallian, 2020), including the
validated one, murine double minute 2 (MDM2) (Xiao et
al., 2011; Zhou et al., 2014). In light of the possibility that
the G allele of rs2043556 may promote BC progression
via the upregulation of relevant oncogenes, studies have
been conducted to examine whether miR-605 rs2043556
was associated with the risk of BC. The G allele was proven
to significantly increase the risk of BC in Iranian [G vs.
A: OR = 2.159, 95% CI = 1.56–2.99, P = 3 Í 10-6 (Kazemi
and Vallian, 2020)], Asian (Chen et al., 2014b), and South
American (Morales et al., 2018) populations.
4. SNPs in mature miRNA sequence and BC
The miRNA-RISC complex is guided to the complementary
sequences in the 3′UTR of target transcripts by mature
miRNAs. The site-specific mRNA is cleavaged when the
pairing is almost complete, or the translation is inhibited
when imperfect base pairing occurs (Sun et al., 2009).
Base pairing between 6 or 7 consecutive nucleotides in the
target mRNAs 3′UTR and when the seed sequence of the
miRNAs 5′ end (2–7 or 2–8 nucleotides) play a critical role
in the interactions of miRNA and mRNA. The available
findings suggested that any variant in the seed sequence
could change the level of their miRNA and might also
generate a novel miRNA, which would then affect their
downstream targets.
In BC, 4 SNPs in the mature miRNA sequence (miRSNPs), rs4919510, rs11614913, rs3746444, and rs2910164,
were found to be associated with the risk of the disease.
The potential effects of these miR-SNPs on the miRNA
level and the expression of their target genes are shown in
the Table.
In general, all of these SNPs might affect not only their
target genes, but also their mature miRNA levels, and
therefore potentially induce the increased risk of BC.

4.1. Effect of rs4919510 (C/G) on mature miR-608 in
breast tumorigenesis
SNP rs4919510 (C/G) is located in the mature miRNA
region of miR-608. The G allele of the SNP has been shown
to be associated with the risk of BC in Iranian [G vs. C:
OR = 0.53, 95% CI = 0.30–0.92, P = 0.024 (Hashemi et
al., 2016)] and Chinese [G vs. C: OR = 1.62, 95% CI =
1.23−2.15, P = 3.4 × 10–4 (Huang et al., 2012)] populations.
This association can be explained by the effect on their
target gene, heat shock transcription factor-1 (HSF1). The
G allele of rs4919510 was found to have a lower affinity
to the binding sites of HSF1 3′UTR (Huang et al., 2012),
indicating an increase in the level of HSF1. This high level
of HSF1 was found to be related to the risk of BC (Cheng
et al., 2012). Moreover, in the G-allele predicted structure
(Figure 2), the terminal loop had completely changed,
which might have affected the recognition and cleavage of
Dicer, which may alter the mature products of miR-608
and in turn, affect the level of HSF1.
4.2. Effect of rs11614913 (C/T) on mature miR-196a2 in
breast tumorigenesis
SNP rs11614913 (C/T) is located in the 3p-strand mature
sequence of miR-196a2. The increased risk of BC of the C
allele of rs11614913 was reported in Chinese [CC vs. TT:
OR = 1.37, 95% CI = 1.08–1.74, P = 0.011 (Hu et al., 2009)],
Vietnamese [C vs. T: OR = 1.28, 95% CI = 1.02–1.61, P =
0.033; CC vs. CT + TT: OR = 1.64, 95% CI = 1.15–2.35, P
= 0.006 (Minh et al., 2018)], Asian, and Caucasian [CC vs.
TT: OR = 1.30, 95% CI = 1.01–1.68, P = 0.028 (Qiu et al.,
2011)] populations.
The miRNA structure prediction (Figure 2) found a
minor change, wherein 2 bases in the variant position in
the C allele structure (≥ 99%) were more probable than
in the T allele structure (90%–94%), indicating the higher
possibility of an extra internal loop formation in the T
allele structure. The presence of an additional loop in this
position might suppress the processing by Dicer into the
mature form of miR-196a2. In a study where a comparison
was made between 2 variants of the SNP rs11614913, BC
cells transfected with the C allele exhibited a higher mature
miR-196a2 level than those transfected with the T allele
(Hoffman et al., 2009). The increased level of miR-196a2
with the C allele might inhibit the expression of homeobox
D10 (HOXD10) and enhance TOX high mobility group box
family member 3 (TOX3)/trinucleotide repeat-containing
9 (TNRC9) expression, which have roles in the invasion,
metastasis, and DNA repair progress in BC (Easton et al.,
2007; Ma et al., 2007; Stacey et al., 2007).
4.3. Effect of rs3746444 (A/G) on mature miR-499a in
breast tumorigenesis
SNP rs3746444 (A/G) is located at the 3p and 5p mature
miRNA regions of miR-499a. In the RNA structure
prediction, there was no difference in the secondary
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Figure 2. Predicted secondary structure of pre-miRNA with 2 alleles of miR-SNP in the mature region. Sites of the SNPs are indicated
with arrows. This figure was predicted using the webserver at https://rna.urmc.rochester.edu/RNAstructureWeb/.

structure (Figure 2). However, the G allele of this SNP was
proven to be significantly associated with increased BC
susceptibility in Asian and Caucasian populations [G vs.
A: OR = 1.17, P = 0.008 (Zhang et al., 2017a); G vs. A: OR
= 1.18, 95% CI = 1.09–1.27, P = 0.04 (Yan et al., 2017)].
Furthermore, a decreased miR-499a-5p expression was
observed in breast tissues with the G allele of rs3746444
(Alshatwi et al., 2012). The hypothesis was that the G allele
of rs3746444 might decrease the miR-499a-5p expression
(under an unknown mechanism), which may increase Srytype HMG box (SOX) expression (Li et al., 2013) leading
to the activation of the Wnt/β-catenin signaling pathway
in an abnormal manner, which has been associated with
breast tumorigenesis and tumor progression.
4.4. Effect of rs2910164 (G/C) on mature miR-146a in
breast tumorigenesis
SNP rs2910164 (G/C) is located in the internal loop and
mature region of the miR-146a gene. Previous findings
have indicated that the C allele of the SNP rs2910164
increased the risk of BC among European [OR = 1.29, 95%
CI = 1.02–1.63, P = 0.032 (Lian et al., 2012)] and Caucasian
[OR = 1.31, 95% CI = 1.05–1.65, P = 0.02 (Dai et al., 2015)]
populations. In 2018, a study conducted in a Vietnamese
population also revealed an increased risk among CG
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genotype carriers [CG vs. CC + GG: OR = 1.44, 95% CI
= 1.04–1.98, P = 0.027 (Minh et al., 2018)]. However, the
heterozygous variant GC and the C allele were associated
with reduced risk in a North Indian population [GC vs.
GG: OR = 0.5, 95% CI = 0.31–0.87, P = 0.013; C vs. G: OR
= 0.6, 95% CI = 0.4–0.8, P = 0.01 (Bansal et al., 2014)].
The evidence from the published literature clearly showed
that rs2910164 in pre-miR-146a may contribute to genetic
susceptibility to BC. However, the relationship varied
among different populations, which may have been due to
interaction with other genetic factors in each population.
By predicting the impact of the variant (C/G) of rs2910164
on the secondary structure of the miR-146a precursor,
the C allele was found to create 2 internal loops around
the cleavage site of Dicer, while the G allele created only
1 internal loop (Figure 2). This difference implied that the
C allele might generate more mature miR-146a than the
G allele, which was confirmed in the study of Shen et al.
(2008) (P = 0.013). Due to the high level of miR-146a,
the C allele structure could inhibit more BC 1 (BRCA1)
mRNA than the G allele (P = 0.046) (Shen et al., 2008).
Downregulation of BRCA1 reduces the DNA repair
function and allows damage cells to progress into S phase,
resulting in breast tumorigenesis (Deng, 2006).
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5. Conclusion
MiRNAs are small RNAs that regulate various fundamental
cell processes by suppressing the expression of their
target genes. All types of miR-SNPs can contribute to the
development of the malignant tumors, including BC. Casecontrol studies in different populations have been able to
distinguish specific miR-SNPs and predict their effects on
the risk of BC for each ethnicity. Therefore, miR-SNPs may
act as predictive markers for the risk of BC to support the
improvement of early diagnosis and prognosis strategies.
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